Viridian Therapeutics, Inc.\DE (VRDN) Other Non-Current Assets (2013 - 2026)

Viridian Therapeutics, Inc.\DE's Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $888000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 81.6% year-over-year to $888000.0; the TTM figure through Mar 2026 stood at $888000.0 (up 81.6% YoY), while the FY2025 annual figure was $1.5 million, up 206.59% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $888000.0, down from $1.5 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $1.5 million in Q1 2022, with the low at $489000.0 in Q1 2025.
• The 5-year median for Other Non-Current Assets is $982000.0 (2022), against an average of $983764.7.
• The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets surged 154100.0% in 2022, then slumped 44.34% in 2024.
• Viridian Therapeutics, Inc.\DE's Other Non-Current Assets stood at $982000.0 in 2022, then slumped by 38.49% to $604000.0 in 2023, then retreated by 17.05% to $501000.0 in 2024, then surged by 206.59% to $1.5 million in 2025, then tumbled by 42.19% to $888000.0 in 2026.
• Business Quant data shows VRDN's Other Non-Current Assets at $888000.0 in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.